Differential distribution of ErbB-2 and pS2 proteins in ductal carcinomain situ of the breast
- 1 February 1996
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 37 (1) , 89-92
- https://doi.org/10.1007/bf01806635
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.1994
- Immunohistochemical survey of pS2 expression in intraductal lesions associated with invasive ductal carcinoma of the breastInternational Journal of Cancer, 1993
- 17 beta-estradiol mimics ligand activity of the c-erbB2 protooncogene product.Proceedings of the National Academy of Sciences, 1993
- Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast CancerNew England Journal of Medicine, 1993
- Estrogen receptor immunohistoohemistry in carcinoma in situ of the breastCancer, 1992
- Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinomain situBreast Cancer Research and Treatment, 1991
- Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breastThe American Journal of Surgery, 1990
- Flow cytometric and histological analysis of ductal carcinoma in situ of the breastBritish Journal of Surgery, 1990
- Cell kinetics of histologic variants ofin situ breast carcinomaBreast Cancer Research and Treatment, 1986
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981